Indeed Snapshot

Track Neos Therapeutics reviews on Indeed to uncover insights on employee sentiment

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Profile Url Name Website Industry Description Revenue Headquarters location CEO Rating: CEO (%) Rating: CEO Responses Count Rating: Overall Happiness: Compensation score Happiness: Support score Happiness: Purpose score Happiness: Flexibility score Happiness: Energy score Happiness: Work Happiness score Happiness: Trust score Happiness: Learning score Happiness: Belonging score Happiness: Inclusion score Happiness: Overall score Happiness: Appreciation score Happiness: Achievement score Happiness: Responses Count Review Count Ratings Responses Count Rating: Culture & Values Rating: Compensation & Benefits Rating: Job Security & Advancement Rating: Senior Management Rating: Worklife Balance Interview: Duration Responses count Interview Duration Interview: Difficulty Responses count Interview Difficulty Interview: Experience Responses count Interview Experience Work Culture: Stressful (0) to Relaxed (1) Ratio Work Culture: Slow Paced (0) to Fast Paced (1) Ratio Work Culture: Competitive (0) to Collaborative (1) Ratio Date Added Date Updated Company Name Sector Industry
nasdaq:neos https://www.indeed.com/cmp/neos-therapeutics Aug 29th, 2022 12:00AM Open Neos Therapeutics Pharmaceutical & Biotechnology Neos Therapeutics develops, manufactures, and commercializes innovative extended-release (XR) products using our proprietary extended-release drug delivery and orally disintegrating tablet (ODT) technology platforms. We have two FDA approved products for the treatment of ADHD and both utilize our extended-release ODT technology. Our third branded ADHD product candidate is an extended-release oral suspension. Our growing ADHD Product Portfolio puts Neos in a unique position to help meet the different needs of patients that struggle with ADHD. RRv1_5M_25M Grand Prairie, TX Vipin Garg, Ph.D. 2.90 23.00 23.00 2.60 3.00 2.10 2.40 2.90 15.00 About two weeks 18.00 MEDIUM 17.00 FAVORABLE Aug 29th, 2022 12:20PM Aug 29th, 2022 12:20PM Neos Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:neos https://www.indeed.com/cmp/neos-therapeutics Aug 28th, 2022 12:00AM Open Neos Therapeutics Pharmaceutical & Biotechnology Neos Therapeutics develops, manufactures, and commercializes innovative extended-release (XR) products using our proprietary extended-release drug delivery and orally disintegrating tablet (ODT) technology platforms. We have two FDA approved products for the treatment of ADHD and both utilize our extended-release ODT technology. Our third branded ADHD product candidate is an extended-release oral suspension. Our growing ADHD Product Portfolio puts Neos in a unique position to help meet the different needs of patients that struggle with ADHD. RRv1_5M_25M Grand Prairie, TX Vipin Garg, Ph.D. 2.90 23.00 23.00 2.60 3.00 2.10 2.40 2.90 15.00 About two weeks 18.00 MEDIUM 17.00 FAVORABLE Aug 28th, 2022 05:19AM Aug 28th, 2022 05:19AM Neos Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:neos https://www.indeed.com/cmp/neos-therapeutics Aug 27th, 2022 12:00AM Open Neos Therapeutics Pharmaceutical & Biotechnology Neos Therapeutics develops, manufactures, and commercializes innovative extended-release (XR) products using our proprietary extended-release drug delivery and orally disintegrating tablet (ODT) technology platforms. We have two FDA approved products for the treatment of ADHD and both utilize our extended-release ODT technology. Our third branded ADHD product candidate is an extended-release oral suspension. Our growing ADHD Product Portfolio puts Neos in a unique position to help meet the different needs of patients that struggle with ADHD. RRv1_5M_25M Grand Prairie, TX Vipin Garg, Ph.D. 2.90 23.00 23.00 2.60 3.00 2.10 2.40 2.90 15.00 About two weeks 18.00 MEDIUM 17.00 FAVORABLE Aug 27th, 2022 04:39AM Aug 27th, 2022 04:39AM Neos Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:neos https://www.indeed.com/cmp/neos-therapeutics Aug 25th, 2022 12:00AM Open Neos Therapeutics Pharmaceutical & Biotechnology Neos Therapeutics develops, manufactures, and commercializes innovative extended-release (XR) products using our proprietary extended-release drug delivery and orally disintegrating tablet (ODT) technology platforms. We have two FDA approved products for the treatment of ADHD and both utilize our extended-release ODT technology. Our third branded ADHD product candidate is an extended-release oral suspension. Our growing ADHD Product Portfolio puts Neos in a unique position to help meet the different needs of patients that struggle with ADHD. RRv1_5M_25M Grand Prairie, TX Vipin Garg, Ph.D. 2.90 23.00 23.00 2.60 3.00 2.10 2.40 2.90 15.00 About two weeks 18.00 MEDIUM 17.00 FAVORABLE Aug 25th, 2022 09:18AM Aug 25th, 2022 09:18AM Neos Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:neos https://www.indeed.com/cmp/neos-therapeutics Aug 23rd, 2022 12:00AM Open Neos Therapeutics Pharmaceutical & Biotechnology Neos Therapeutics develops, manufactures, and commercializes innovative extended-release (XR) products using our proprietary extended-release drug delivery and orally disintegrating tablet (ODT) technology platforms. We have two FDA approved products for the treatment of ADHD and both utilize our extended-release ODT technology. Our third branded ADHD product candidate is an extended-release oral suspension. Our growing ADHD Product Portfolio puts Neos in a unique position to help meet the different needs of patients that struggle with ADHD. RRv1_5M_25M Grand Prairie, TX Vipin Garg, Ph.D. 2.90 23.00 23.00 2.60 3.00 2.10 2.40 2.90 15.00 About two weeks 18.00 MEDIUM 17.00 FAVORABLE Aug 23rd, 2022 11:11AM Aug 23rd, 2022 11:11AM Neos Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:neos https://www.indeed.com/cmp/neos-therapeutics Aug 21st, 2022 12:00AM Open Neos Therapeutics Pharmaceutical & Biotechnology Neos Therapeutics develops, manufactures, and commercializes innovative extended-release (XR) products using our proprietary extended-release drug delivery and orally disintegrating tablet (ODT) technology platforms. We have two FDA approved products for the treatment of ADHD and both utilize our extended-release ODT technology. Our third branded ADHD product candidate is an extended-release oral suspension. Our growing ADHD Product Portfolio puts Neos in a unique position to help meet the different needs of patients that struggle with ADHD. RRv1_5M_25M Grand Prairie, TX Vipin Garg, Ph.D. 2.90 23.00 23.00 2.60 3.00 2.10 2.40 2.90 15.00 About two weeks 18.00 MEDIUM 17.00 FAVORABLE Aug 21st, 2022 12:55PM Aug 21st, 2022 12:55PM Neos Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:neos https://www.indeed.com/cmp/neos-therapeutics Aug 20th, 2022 12:00AM Open Neos Therapeutics Pharmaceutical & Biotechnology Neos Therapeutics develops, manufactures, and commercializes innovative extended-release (XR) products using our proprietary extended-release drug delivery and orally disintegrating tablet (ODT) technology platforms. We have two FDA approved products for the treatment of ADHD and both utilize our extended-release ODT technology. Our third branded ADHD product candidate is an extended-release oral suspension. Our growing ADHD Product Portfolio puts Neos in a unique position to help meet the different needs of patients that struggle with ADHD. RRv1_5M_25M Grand Prairie, TX Vipin Garg, Ph.D. 2.90 23.00 23.00 2.60 3.00 2.10 2.40 2.90 15.00 About two weeks 18.00 MEDIUM 17.00 FAVORABLE Aug 20th, 2022 02:32PM Aug 20th, 2022 02:32PM Neos Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:neos https://www.indeed.com/cmp/neos-therapeutics Aug 19th, 2022 12:00AM Open Neos Therapeutics Pharmaceutical & Biotechnology Neos Therapeutics develops, manufactures, and commercializes innovative extended-release (XR) products using our proprietary extended-release drug delivery and orally disintegrating tablet (ODT) technology platforms. We have two FDA approved products for the treatment of ADHD and both utilize our extended-release ODT technology. Our third branded ADHD product candidate is an extended-release oral suspension. Our growing ADHD Product Portfolio puts Neos in a unique position to help meet the different needs of patients that struggle with ADHD. RRv1_5M_25M Grand Prairie, TX Vipin Garg, Ph.D. 2.90 23.00 23.00 2.60 3.00 2.10 2.40 2.90 15.00 About two weeks 18.00 MEDIUM 17.00 FAVORABLE Aug 19th, 2022 12:55PM Aug 19th, 2022 12:55PM Neos Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:neos https://www.indeed.com/cmp/neos-therapeutics Aug 18th, 2022 12:00AM Open Neos Therapeutics Pharmaceutical & Biotechnology Neos Therapeutics develops, manufactures, and commercializes innovative extended-release (XR) products using our proprietary extended-release drug delivery and orally disintegrating tablet (ODT) technology platforms. We have two FDA approved products for the treatment of ADHD and both utilize our extended-release ODT technology. Our third branded ADHD product candidate is an extended-release oral suspension. Our growing ADHD Product Portfolio puts Neos in a unique position to help meet the different needs of patients that struggle with ADHD. RRv1_5M_25M Grand Prairie, TX Vipin Garg, Ph.D. 2.90 23.00 23.00 2.60 3.00 2.10 2.40 2.90 15.00 About two weeks 18.00 MEDIUM 17.00 FAVORABLE Aug 18th, 2022 04:39AM Aug 18th, 2022 04:39AM Neos Therapeutics Health Care Pharmaceuticals & Biotechnology
nasdaq:neos https://www.indeed.com/cmp/neos-therapeutics Aug 17th, 2022 12:00AM Open Neos Therapeutics Pharmaceutical & Biotechnology Neos Therapeutics develops, manufactures, and commercializes innovative extended-release (XR) products using our proprietary extended-release drug delivery and orally disintegrating tablet (ODT) technology platforms. We have two FDA approved products for the treatment of ADHD and both utilize our extended-release ODT technology. Our third branded ADHD product candidate is an extended-release oral suspension. Our growing ADHD Product Portfolio puts Neos in a unique position to help meet the different needs of patients that struggle with ADHD. RRv1_5M_25M Grand Prairie, TX Vipin Garg, Ph.D. 2.90 23.00 23.00 2.60 3.00 2.10 2.40 2.90 15.00 About two weeks 18.00 MEDIUM 17.00 FAVORABLE Aug 17th, 2022 10:18AM Aug 17th, 2022 10:18AM Neos Therapeutics Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.